<http://webisa.webdatacommons.org/prov/341264682>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/313808077> .
<http://webisa.webdatacommons.org/prov/383278333>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/313808077> .
<http://webisa.webdatacommons.org/313808077>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/313808077>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<riversideonline.com> .
<http://webisa.webdatacommons.org/313808077>	<http://www.w3.org/ns/prov#value>	"Injections of the medications octreotide (Sandostatin) and lanreotide (Somatuline Depot) may reduce the signs and symptoms of carcinoid syndrome, including skin flushing and diarrhea." .